Congenital cytomegalovirus infection: Impairment and immunization

Journal of Infectious Diseases

Volumn 195, Issue 6, 2007, Pages 767-769

  Pass, Robert F ^a  

^a University of Alabama at Birmingham and Children's Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONNEXIN 26; CYTOMEGALOVIRUS VACCINE; GP83 VACCINE; GPCMV GLYCOPROTEIN VACCINE; UNCLASSIFIED DRUG;

CYTOMEGALOVIRUS INFECTION; EDITORIAL; GENE; GJB2 GENE; HUMAN; IMMUNIZATION; NEWBORN SCREENING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; UL83 GENE; VACCINE PRODUCTION; VIRUS PATHOGENESIS; VIRUS TRANSMISSION;

CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FETAL BLOOD; GENETIC PREDISPOSITION TO DISEASE; HEARING LOSS, SENSORINEURAL; HUMANS; INFANT, NEWBORN; MASS SCREENING;

EID: 33847656646     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/511991     Document Type: Editorial

References (13)

1. Smith MG. Propagation in tissue cultures of a cytopathogenic virus from human salivary gland virus (SGV) disease. Proc Soc Exp Biol Med 1956; 92:418-24.
2. Weller TH, Macaulay JC, Craig JM, Wirth P. Isolation of intranuclear inclusion producing agents from infants with illnesses resembling cytomegalic inclusion disease. Proc Soc Exp Biol Med 1957; 94:4-12.
3. Ogawa H, Suzutani T, Baba Y, et al. Etiology of severe sensorineural hearing loss in children: independent impact of congenital cytomegalovirus infection and GJB2 mutations. J Infect Dis 2007; 195:782-8 (in this issue).
4. Schleiss MR, Lacayo JC, Belkaid Y, et al. Preconceptual administration of an alphavirus replicon UL83 (pp65 homolog) vaccine induces humoral and cellular immunity and improves pregnancy outcome in the guinea pig model of congenital cytomegalovirus infection. J Infect Dis 2007; 195:789-98 (in this issue).
5. Hirota K, Muraguchi K, Watabe N, et al. Prospective study on maternal, intrauterine, and perinatal infections with cytomegalovirus in Japan during 1976-1990. J Med Virol 1992; 37:303-6.
6. Ahlfors K. IgG antibodies to cytomegalovirus in a normal urban Swedish population. Scand J Infect Dis 1984; 16:335-7.
7. Harris S, Ahlfors K, Ivarsson S, Lemmark B, Svanberg L. Congenital cytomegalovirus infection and sensorineural hearing loss. Ear Hear 1984; 5:352-5.
8. Thompson DC, McPhillips H, Davis R, Lieu TA, Homer CJ, Helfand M. Universal newborn hearing screening: summary of evidence. JAMA 2001; 286:2000-10.
9. Kimberlin DW, Lin CY, Sanchez PJ, et al. Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial. J Pediatr 2003; 143:16-25.
10. Stratton K, Durch J, Lawrence R. Vaccines for the 21st century: a tool for decisionmaking. Washington, DC: National Academy Press, 2001.
11. McGregor A, Liu F, Schleiss MR. Molecular, biological and in vivo characterization of the guinea pig cytomegalovirus (GPCMV) homologs of the HCMV matrix proteins, pp71 (UL82) and pp65 (UL83). J Virol 2004; 78:9872-89.
12. Bourne N, Schleiss MR, Bravo F, Bernstein DI. Preconception immunization with a cytomegalovirus (CMV) glycoprotein vaccine improves pregnancy outcome in a guinea pig model of congenital CMV infection. J Infect Dis 2001; 183:59-64.
13. Schleiss MR, Bourne N, Bernstein DI. Preconception vaccination with a glycoprotein B (gB) DNA vaccine protects against cytomegalovirus (CMV) transmission in the guinea pig model of congenital CMV infection. J Infect Dis 2003; 188:1868-74.